CCP
COLL icon

Clough Capital Partners’s Collegium Pharmaceutical COLL Stock Holding History

Clough Capital Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,700
Closed -$162K – 185
2016
Q2 		$162K Buy
+13,700
New +$226K 0.01% 180

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clough Capital Partners's COLL Position: Q3 2016 in Review

Clough Capital Partners sold out of Collegium Pharmaceutical (COLL) in Q3 2016, closing a stake of 13,700 shares — an estimated $162K sold.

Clough Capital Partners first reported a position in COLL in Q2 2016 and held it in 1 quarter. The position peaked at $162K in Q2 2016. 71 funds tracked by Wall St. Rank hold COLL as of Q3 2016.

  • Clough Capital Partners reported no remaining Collegium Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Clough Capital Partners sold 13,700 Collegium Pharmaceutical shares in Q3 2016, an estimated $162K.
  • Clough Capital Partners first reported a position in Collegium Pharmaceutical in Q2 2016 and held it in 1 quarter.
  • Clough Capital Partners's Collegium Pharmaceutical position peaked at $162K in Q2 2016.
  • 71 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2016.

Based on Clough Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.